Recent developments in the immunobiology of rheumatoid arthritis

Arthritis Research and Therapy

Volumn 10, Issue 2, 2008, Pages

  Andersson, Anna K ^a   Li, Ching ^a   Brennan, Fionula M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; CYTOKINE; METHOTREXATE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE N22; RITUXIMAB; STAT4 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR C5; UNCLASSIFIED DRUG; AUTOANTIGEN;

ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; B LYMPHOCYTE; CELL ACTIVATION; CELL TRANSPORT; COMBINATION CHEMOTHERAPY; CYTOKINE PRODUCTION; GENETIC ASSOCIATION; GENETIC RISK; HELPER CELL; HLA TYPING; HUMAN; IMMUNOBIOLOGY; IMMUNOPATHOGENESIS; LYMPHOCYTE FUNCTION; MOLECULAR INTERACTION; MONOTHERAPY; NONHUMAN; OSTEOCLAST; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION; TH17 CELL; ANIMAL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 51549113784     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2370     Document Type: Review

References (112)

1. Ruderman EM Pope RM The evolving clinical profile of abatacept (CTLA4-Ig): A novel costimulatory modulator for the treatment of rheumatoid arthritis Arthritis Res Ther 2005, 7(Suppl 2):S21-S25. 10.1186/ar1688 15833145
2. Edwards JC Szczepanski L Szechinski J Filipowicz-Sosnowska A Emery P Close DR Stevens RM Shaw T Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis N Engl J Med 2004, 350:2572-2581. 10.1056/NEJMoa032534 15201414
3. Martinez-Gamboa L Brezinschek HP Burmester GR Dorner T Immunopathologic role of B lymphocytes in rheumatoid arthritis: Rationale of B cell-directed therapy Autoimmun Rev 2006, 5:437-442. 10.1016/ j.autrev.2006.02.004 16920569
4. Takemura S Klimiuk PA Braun A Goronzy JJ Weyand CM T cell activation in rheumatoid synovium is B cell dependent J Immunol 2001, 167:4710-4718. 11591802
5. Firestein GS Zvaifler NJ How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end Arthritis Rheum 2002, 46:298-308. 10.1002/art.502 11840432
6. Stastny P Association of the B-cell alloantigen DRw4 with rheumatoid arthritis N Engl J Med 1978, 298:869-871. 147420
7. Cope AP Sonderstrup G Evaluating candidate autoantigens in rheumatoid arthritis Springer Semin Immunopathol 1998, 20:23-39. 10.1007/BF00831997 9836367
8. Malone DG Wahl SM Tsokos M Cattell H Decker JL Wilder RL Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics J Clin Invest 1984, 74:1173-1185. 425283 6384266 10.1172/JCI111526
9. Emery P Panayi GS Welsh KI Cole BC Relationship of HLA-DR4 to defective cellular immunity in rheumatoid arthritis using PPD, and mycoplasma and lectin mitogens J Rheumatol 1985, 12:859-864. 3878876
10. Cope AP Londei M Chu NR Cohen SB Elliott MJ Brennan FM Maini RN Feldmann M Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis J Clin Invest 1994, 94:749-760. 296155 8040330 10.1172/JCI117394
11. Brennan FM Hayes AL Ciesielski CJ Green P Foxwell BM Feldmann M Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: Involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis Arthritis Rheum 2002, 46:31-41. 10.1002/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO;2-5 11822409
12. Schulze-Koops H Davis LS Haverty TP Wacholtz MC Lipsky PE Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4 J Rheumatol 1998, 25:2065-2076. 9818646
13. Choy EH Connolly DJ Rapson N Jeal S Brown JC Kingsley GH Panayi GS Johnston JM Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients Rheumatology (Oxford) 2000, 39:1139-1146. 10.1093/rheumatology/39.10.1139 11035136
14. Mason U Aldrich J Breedveld F Davis CB Elliott M Jackson M Jorgensen C Keystone E Levy R Tesser J Totoritis M Truneh A Weisman M Wiesenhutter C Yocum D Zhu J CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis J Rheumatol 2002, 29:220-229. 11838838
15. Choy EH Panayi GS Emery P Madden S Breedveld FC Kraan MC Kalden JR Rascu A Brown JC Rapson N Johnston JM Repeatcycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial Rheumatology (Oxford) 2002, 41:1142-1148. 10.1093/rheumatology/41.10.1142 12364634
16. Kremer JM Dougados M Emery P Durez P Sibilia J Shergy W Steinfeld S Tindall E Becker JC Li T Nuamah IF Aranda R Moreland LW Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: A randomized trial Ann Intern Med 2006, 144:865-876. 16785475
17. Genant HK Peterfy CG Westhovens R Becker JC Aranda R Vratsanos G Teng J Kremer JM Abatacept inhibits structural damage progression in rheumatoid arthritis: Results from the long-term extension of the AIM trial Ann Rheum Dis 2007.
18. Schiff M Keiserman M Codding C Songcharoen S Berman A Nayiager S Saldate C Li T Aranda R Becker JC Lin C Cornet PL Dougados M Efficacy and safety of abatacept or infliximab versus placebo in ATTEST: A phase III, multicenter, randomized, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate Ann Rheum Dis 2007.
19. Kremer JM Dougados M Emery P Durez P Sibilia J Shergy W Steinfeld S Tindall E Becker JC Li T Nuamah IF Aranda R Moreland LW Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial Arthritis Rheum 2005, 52:2263-2271. 10.1002/art.21201 16052582
20. Sweeney SE Firestein GS Rheumatoid arthritis: Regulation of synovial inflammation Int J Biochem Cell Biol 2004, 36:372-378. 10.1016/ S1357-2725(03)00259-0 14687914
21. Kop EN Adriaansen J Smeets TJ Vervoordeldonk MJ van Lier RA Hamann J Tak PP CD97 neutralisation increases resistance to collagen-induced arthritis in mice Arthritis Res Ther 2006, 8:R155. 1779430 17007638 10.1186/ar2049
22. Hamann J Wishaupt JO van Lier RA Smeets TJ Breedveld FC Tak PP Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue Arthritis Rheum 1999, 42:650-658. 10.1002/ 1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S 10211878
23. Sharif M Osborne DJ Meadows K Woodhouse SM Colvin EM Shepstone L Dieppe PA The relevance of chondroitin and keratan sulphate markers in normal and arthritic synovial fluid Br J Rheumatol 1996, 35:951-957. 10.1093/ rheumatology/35.10.951 8883432
24. Sebbag M Parry SL Brennan FM Feldmann M Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: Possible relevance to pathophysiology of rheumatoid arthritis Eur J Immunol 1997, 27:624-632. 10.1002/eji.1830270308 9079801
25. McInnes IB Leung BP Sturrock RD Field M Liew FY Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis Nat Med 1997, 3:189-195. 10.1038/nm0297-189 9018238
26. Beech JT Andreakos E Ciesielski CJ Green P Foxwell BM Brennan FM T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFκB: Implications for rheumatoid arthritis Arthritis Res Ther 2006, 8:R168. 1794512 17101049 10.1186/ar2077
27. Tran CN Lundy SK White PT Endres JL Motyl CD Gupta R Wilke CM Shelden EA Chung KC Urquhart AG Fox DA Molecular interactions between T cells and fibroblast-like synoviocytes. Role of membrane tumor necrosis factor-α on cytokine-activated T cells Am J Pathol 2007, 171:1588-1598. 10.2353/ajpath.2007.070004 17823284
28. Gonzalez-Alvaro I Dominguez-Jimenez C Ortiz AM Nunez-Gonzalez V Roda-Navarro P Fernandez-Ruiz E Sancho D Sanchez-Madrid F Interleukin-15 and interferon-gamma participate in the cross-talk between natural killer and monocytic cells required for tumour necrosis factor production Arthritis Res Ther 2006, 8:R88. 1779407 16684368 10.1186/ ar1955
29. Baslund B Tvede N Danneskiold-Samsoe B Larsson P Panayi G Petersen J Petersen LJ Beurskens FJ Schuurman J van de Winkel JG Parren PW Gracie JA Jongbloed S Liew FY McInnes IB Targeting interleukin-15 in patients with rheumatoid arthritis: A proof-of-concept study Arthritis Rheum 2005, 52:2686-2692. 10.1002/art.21249 16142748
30. Huang SH Frydas S Kempuraj D Barbacane RC Grilli A Boucher W Letourneau R Madhappan B Papadopoulou N Verna N De Lutiis MA Iezzi T Riccioni G Theoharides TC Conti P Interleukin-17 and the interleukin-17 family member network Allergy Asthma Proc 2004, 25:17-21. 15055556
31. Ryu S Lee JH Kim SI IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes Clin Rheumatol 2006, 25:16-20. 10.1007/s10067-005-1081-1 16163444
32. Jovanovic DV Di Battista JA Martel-Pelletier J Jolicoeur FC He Y Zhang M Mineau F Pelletier JP IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages J Immunol 1998, 160:3513-3521. 9531313
33. Kolls JK Linden A Interleukin-17 family members and inflammation Immunity 2004, 21:467-476. 10.1016/j.immuni.2004.08.018 15485625
34. Kotake S Udagawa N Takahashi N Matsuzaki K Itoh K Ishiyama S Saito S Inoue K Kamatani N Gillespie MT Martin TJ Suda T IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis J Clin Invest 1999, 103:1345-1352. 408356 10225978 10.1172/JCI5703
35. Chabaud M Durand JM Buchs N Fossiez F Page G Frappart L Miossec P Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium Arthritis Rheum 1999, 42:963-970. 10.1002/ 1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E 10323452
36. Hwang SY Kim HY Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients Mol Cell 2005, 19:180-184. 15879699
37. Raza K Falciani F Curnow SJ Ross EJ Lee CY Akbar AN Lord JM Gordon C Buckley CD Salmon M Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin Arthritis Res Ther 2005, 7:R784-R795. 1175027 15987480 10.1186/ar1733
38. Katz Y Nadiv O Beer Y Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: A possible role as a 'fine-tuning cytokine' in inflammation processes Arthritis Rheum 2001, 44:2176-2184. 10.1002/ 1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4 11592383
39. Chabaud M Fossiez F Taupin JL Miossec P Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines J Immunol 1998, 161:409-414. 9647250
40. Ziolkowska M Koc A Luszczykiewicz G Ksiezopolska-Pietrzak K Klimczak E Chwalinska-Sadowska H Maslinski W High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism J Immunol 2000, 164:2832-2838. 10679127
41. Kirkham BW Lassere MN Edmonds JP Juhasz KM Bird PA Lee CS Shnier R Portek IJ Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two-year prospective study (the DAMAGE study cohort) Arthritis Rheum 2006, 54:1122-1131. 10.1002/ art.21749 16572447
42. Lundy SK Sarkar S Tesmer LA Fox DA Cells of the synovium in rheumatoid arthritis. T lymphocytes Arthritis Res Ther 2007, 9:202. 1860060 17306038 10.1186/ar2107
43. Fasth AE Snir O Johansson AA Nordmark B Rahbar A Af Klint E Bjorkstrom NK Ulfgren AK van Vollenhoven RF Malmstrom V Trollmo C Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis Arthritis Res Ther 2007, 9:R87. 2212553 17825098 10.1186/ar2286
44. Smeets TJ Dolhain R Miltenburg AM de Kuiper R Breedveld FC Tak PP Poor expression of T cell-derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue Clin Immunol Immunopathol 1998, 88:84-90. 10.1006/clin.1998.4525 9683554
45. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 2005, 6:1123-1132. 10.1038/ni1254 16200070
46. Lubberts E Koenders MI van den Berg WB The role of T-cell interleukin-17 in conducting destructive arthritis: Lessons from animal models Arthritis Res Ther 2005, 7:29-37. 1064899 15642151 10.1186/ar1478
47. + Th cells that cause autoimmune arthritis J Exp Med 2007, 204:41-47. 2118414 17227914 10.1084/ jem.20062259
48. Sakaguchi N Takahashi T Hata H Nomura T Tagami T Yamazaki S Sakihama T Matsutani T Negishi I Nakatsuru S Sakaguchi S Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice Nature 2003, 426:454-460. 10.1038/nature02119 14647385
49. Bettelli E Carrier Y Gao W Korn T Strom TB Oukka M Weiner HL Kuchroo VK Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 2006, 441:235-238. 10.1038/ nature04753 16648838
50. Mangan PR Harrington LE O'Quinn DB Helms WS Bullard DC Elson CO Hatton RD Wahl SM Schoeb TR Weaver CT Transforming growth factor-beta induces development of the T(H)17 lineage Nature 2006, 441:231-234. 10.1038/ nature04754 16648837
51. Veldhoen M Hocking RJ Atkins CJ Locksley RM Stockinger B TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells Immunity 2006, 24:179-189. 10.1016/j.immuni.2006.01.001 16473830
52. Wilson NJ Boniface K Chan JR McKenzie BS Blumenschein WM Mattson JD Basham B Smith K Chen T Morel F Lecron JC Kastelein RA Cua DJ McClanahan TK Bowman EP de Waal Malefyt R Development, cytokine profile and function of human interleukin 17-producing helper T cells Nat Immunol 2007, 8:950-957. 10.1038/ni1497 17676044
53. Chen Z Tato CM Muul L Laurence A O'Shea JJ Distinct regulation of interleukin-17 in human T helper lymphocytes Arthritis Rheum 2007, 56:2936-2946. 10.1002/art.22866 17763419
54. Kotake S Udagawa N Hakoda M Mogi M Yano K Tsuda E Takahashi K Furuya T Ishiyama S Kim KJ Saito S Nishikawa T Takahashi N Togari A Tomatsu T Suda T Kamatani N Activated human T cells directly induce osteoclastogenesis from human monocytes: Possible role of T cells in bone destruction in rheumatoid arthritis patients Arthritis Rheum 2001, 44:1003-1012. 10.1002/ 1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-# 11352231
55. Shigeyama Y Pap T Kunzler P Simmen BR Gay RE Gay S Expression of osteoclast differentiation factor in rheumatoid arthritis Arthritis Rheum 2000, 43:2523-2530. 10.1002/ 1529-0131(200011)43:11<2523::AID-ANR20>3.0.CO;2-Z 11083276
56. Miranda-Carus ME Benito-Miguel M Balsa A CoboIbanez T Perez de Ayala C Pascual-Salcedo D Martin-Mola E Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes Arthritis Rheum 2006, 54:1151-1164. 10.1002/ art.21731 16575870
57. Sato K Suematsu A Okamoto K Yamaguchi A Morishita Y Kadono Y Tanaka S Kodama T Akira S Iwakura Y Cua DJ Takayanagi H Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction J Exp Med 2006, 203:2673-2682. 2118166 17088434 10.1084/ jem.20061775
58. Yago T Nanke Y Kawamoto M Furuya T Kobashigawa T Kamatani N Kotake S IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats Arthritis Res Ther 2007, 9:R96. 2212562 17888176 10.1186/ar2297
59. Firestein GS Yeo M Zvaifler NJ Apoptosis in rheumatoid arthritis synovium J Clin Invest 1995, 96:1631-1638. 185789 7657832 10.1172/ JCI118202
60. Raza K Scheel-Toellner D Lee CY Pilling D Curnow SJ Falciani F Trevino V Kumar K Assi LK Lord JM Gordon C Buckley CD Salmon M Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis Arthritis Res Ther 2006, 8:R120. 1779404 16859518 10.1186/ ar2009
61. Arnold R Brenner D Becker M Frey CR Krammer PH How T lymphocytes switch between life and death Eur J Immunol 2006, 36:1654-1658. 10.1002/ eji.200636197 16791883
62. Scatizzi JC Hutcheson J Bickel E Haines GK 3rd Perlman H Pro-apoptotic Bid is required for the resolution of the effector phase of inflammatory arthritis Arthritis Res Ther 2007, 9:R49. 2206343 17509138 10.1186/ar2204
63. Kuo CC Lin SC Altered FOXO1 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients Mol Med 2007, 13:561-566. 1976859 17873969 10.2119/ 2007-00021.Kuo
64. Ludikhuize J de Launay D Groot D Smeets TJ Vinkenoog M Sanders ME Tas SW Tak PP Reedquist KA Inhibition of fork-head box class O family member transcription factors in rheumatoid synovial tissue Arthritis Rheum 2007, 56:2180-2191. 10.1002/art.22653 17599731
65. Rouse BT Regulatory T cells in health and disease J Intern Med 2007, 262:78-95. 10.1111/j.1365-2796.2007.01836.x 17598816
66. + T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis Scand J Immunol 2005, 62:312-317. 10.1111/ j.1365-3083.2005.01656.x 16179019
67. van Amelsfort JM Jacobs KM Bijlsma JW Lafeber FP Taams LS CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid Arthritis Rheum 2004, 50:2775-2785. 10.1002/art.20499 15457445
68. + T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis Clin Exp Immunol 2005, 140:360-367. 1809357 15807863 10.1111/j.1365-2249.2005.02754.x
69. + T cells from the target organ of patients with rheumatoid arthritis Eur J Immunol 2003, 33:215-223. 10.1002/immu.200390024 12594850
70. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease Arthritis Res Ther 2004, 6:R335-R346. 464877 15225369 10.1186/ar1192
71. + regulatory T cells Nat Immunol 2003, 4:330-336. 10.1038/ni904 12612578
72. + Tregs J Clin Invest 2005, 115:3276-3284. 1242190 16211090 10.1172/JCI24685
73. hi T-regulatory cells Blood 2006, 108:253-261. 1895836 16537805 10.1182/ blood-2005-11-4567
74. Ehrenstein MR Evans JG Singh A Moore S Warnes G Isenberg DA Mauri C Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy J Exp Med 2004, 200:277-285. 2211983 15280421 10.1084/jem.20040165
75. Nadkarni S Mauri C Ehrenstein MR Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β J Exp Med 2007, 204:33-39. 2118431 17200409 10.1084/jem.20061531
76. + regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy Drug Discov Today 2007, 12:548-552. 10.1016/j.drudis.2007.05.002 17631249
77. + regulatory T cells J Immunol 2006, 177:3806-3813. 16951342
78. +CD25-T cells to acquire regulatory cell function Blood 2003, 101:5076-5083. 10.1182/blood-2002-09-2798 12609834
79. Schroder AE Greiner A Seyfert C Berek C Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis Proc Natl Acad Sci USA 1996, 93:221-225. 40210 8552609 10.1073/pnas.93.1.221
80. Mewar D Wilson AG Autoantibodies in rheumatoid arthritis: A review Biomed Pharmacother 2006, 60:648-655. 10.1016/j.biopha.2006.09.002 17064873
81. Schellekens GA Visser H de Jong BA van den Hoogen FH Hazes JM Breedveld FC van Venrooij WJ The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum 2000, 43:155-163. 10.1002/ 1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3 10643712
82. Hoffman IE Peene I Cebecauer L Isenberg D Huizinga TW Union A Meheus L De Bosschere K Hulstaert F Veys EM et al.: Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus Ann Rheum Dis 2005, 64:330-332. 1755357 15647444 10.1136/ard.2004.022111
83. Kuhn KA Kulik L Tomooka B Braschler KJ Arend WP Robinson WH Holers VM Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis J Clin Invest 2006, 116:961-973. 1421345 16585962 10.1172/JCI25422
84. Petkova SB Konstantinov KN Sproule TJ Lyons BL Awwami MA Roopenian DC Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor FcγRIIB J Exp Med 2006, 203:275-280. 2118221 16476768 10.1084/jem.20051951
85. Klareskog L Padyukov L Ronnelid J Alfredsson L Genes, environment and immunity in the development of rheumatoid arthritis Curr Opin Immunol 2006, 18:650-655. 10.1016/j.coi.2006.06.004 17010589
86. Orozco G Rueda B Martin J Genetic basis of rheumatoid arthritis Biomed Pharmacother 2006, 60:656-662. 10.1016/j.biopha.2006.09.003 17055211
87. Lee HS Remmers EF Le JM Kastner DL Bae SC Gregersen PK Association of STAT4 with rheumatoid arthritis in the Korean population Mol Med 2007, 13:455-460. 2014726 17932559
88. Remmers EF Plenge RM Lee AT Graham RR Hom G Behrens TW de Bakker PI Le JM Lee HS Batliwalla F Li W Masters SL Booty MG Carulli JP Padyukov L Alfredsson L Klareskog L Chen WV Amos CI Criswell LA Seldin MF Kastner DL Gregersen PK STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus N Engl J Med 2007, 357:977-986. 10.1056/NEJMoa073003 17804842
89. Plenge RM Seielstad M Padyukov L Lee AT Remmers EF Ding B Liew A Khalili H Chandrasekaran A Davies LR Li W Tan AK Bonnard C Ong RT Thalamuthu A Pettersson S Liu C Tian C Chen WV Carulli JP Beckman EM Altshuler D Alfredsson L Criswell LA Amos CI Seldin MF Kastner DL Klareskog L Gregersen PK TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study N Engl J Med 2007, 357:1199-1209. 10.1056/NEJMoa073491 17804836
90. Kurreeman FA Padyukov L Marques RB Schrodi SJ Seddighzadeh M Stoeken-Rijsbergen G van der Helm-van Mil AH Allaart CF Verduyn W Houwing-Duistermaat J Alfredsson L Begovich AB Klareskog L Huizinga TW Toes RE A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis PLoS Med 2007, 4:e278. 10.1371/ journal.pmed.0040358 1788026
91. Burkhardt H Huffmeier U Spriewald B Bohm B Rau R Kallert S Engstrom A Holmdahl R Reis A Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis Arthritis Rheum 2006, 54:82-89. 10.1002/art.21498 16385499
92. Begovich AB Carlton VE Honigberg LA Schrodi SJ Chokkalingam AP Alexander HC Ardlie KG Huang Q Smith AM Spoerke JM Conn MT Chang M Chang SY Saiki RK Catanese JJ Leong DU Garcia VE McAllister LB Jeffery DA Lee AT Batliwalla F Remmers E Criswell LA Seldin MF Kastner DL Amos CI Sninsky JJ Gregersen PK A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis Am J Hum Genet 2004, 75:330-337. 1216068 15208781 10.1086/422827
93. Hinks A Barton A John S Bruce I Hawkins C Griffiths CE Donn R Thomson W Silman A Worthington J Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: Further support that PTPN22 is an autoimmunity gene Arthritis Rheum 2005, 52:1694-1699. 10.1002/art.21049 15934099
94. Bottini N Vang T Cucca F Mustelin T Role of PTPN22 in type 1 diabetes and other autoimmune diseases Semin Immunol 2006, 18:207-213. 10.1016/ j.smim.2006.03.008 16697661
95. Johansson M Arlestig L Hallmans G Rantapaa-Dahlqvist S PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease Arthritis Res Ther 2006, 8:R19. 1526580 16507117 10.1186/ar1868
96. Pierer M Kaltenhauser S Arnold S Wahle M Baerwald C Hantzschel H Wagner U Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: Higher frequency of the risk allele in male compared to female patients Arthritis Res Ther 2006, 8:R75. 1526616 16635271 10.1186/ar1945
97. Mastana S Gilmour A Ghelani A Smith H Samanta A Association of PTPN22 with rheumatoid arthritis among South Asians in the UK J Rheumatol 2007, 34:1984-1986. 17696275
98. Ikari K Momohara S Inoue E Tomatsu T Hara M Yamanaka H Kamatani N Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population Rheumatology (Oxford) 2006, 45:1345-1348. 10.1093/rheumatology/kel169 16690758
99. Jawaheer D Seldin MF Amos CI Chen WV Shigeta R Etzel C Damle A Xiao X Chen D Lum RF Monteiro J Kern M Criswell LA Albani S Nelson JL Clegg DO Pope R Schroeder HW Jr Bridges SL Jr Pisetsky DS Ward R Kastner DL Wilder RL Pincus T Callahan LF Flemming D Wener MH Gregersen PK Screening the genome for rheumatoid arthritis susceptibility genes: A replication study and combined analysis of 512 multicase families Arthritis Rheum 2003, 48:906-916. 10.1002/art.10989 12687532
100. Frucht DM IL-23: A cytokine that acts on memory T cells Sci STKE 2002, 2002:PE1. 11784889
101. Mathur AN Chang HC Zisoulis DG Stritesky GL Yu Q O'Malley JT Kapur R Levy DE Kansas GS Kaplan MH Stat3 and Stat4 direct development of IL-17-secreting Th cells J Immunol 2007, 178:4901-4907. 17404271
102. Bettelli E Oukka M Kuchroo VK T(H)-17 cells in the circle of immunity and autoimmunity Nat Immunol 2007, 8:345-350. 10.1038/ni0407-345 17375096
103. Kikly K Liu L Na S Sedgwick JD The IL-23/Th(17) axis: Therapeutic targets for autoimmune inflammation Curr Opin Immunol 2006, 18:670-675. 10.1016/j.coi.2006.09.008 17010592
104. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Nature 2007, 447:661-678. 10.1038/nature05911 17554300
105. Murdoch C Muthana M Lewis CE Hypoxia regulates macrophage functions in inflammation J Immunol 2005, 175:6257-6263. 16272275
106. Ling S Li Z Borschukova O Xiao L Pumpens P Holoshitz J The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway Arthritis Res Ther 2007, 9:R5. 1865041 17254342 10.1186/ar2111
107. van der Helm-van Mil AH Verpoort KN Breedveld FC Huizinga TW Toes RE de Vries RR The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis Arthritis Rheum 2006, 54:1117-1121. 10.1002/art.21739 16572446
108. Klareskog L Stolt P Lundberg K Kallberg H Bengtsson C Grunewald J Ronnelid J Harris HE Ulfgren AK Rantapaa-Dahlqvist S Eklund A Padyukov L Alfredsson L A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination Arthritis Rheum 2006, 54:38-46. 10.1002/art.21575 16385494
109. Mewar D Coote A Moore DJ Marinou I Keyworth J Dickson MC Montgomery DS Binks MH Wilson AG Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis Arthritis Res Ther 2006, 8:R128. 1779371 16859535 10.1186/ar2017
110. Linn-Rasker SP van der Helm-van Mil AH van Gaalen FA Kloppenburg M de Vries RR le Cessie S Breedveld FC Toes RE Huizinga TW Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles Ann Rheum Dis 2006, 65:366-371. 10.1136/ard.2005.041079 16014670
111. Pedersen M Jacobsen S Klarlund M Pedersen BV Wiik A Wohlfahrt J Frisch M Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides Arthritis Res Ther 2006, 8:R133. 1779386 16872514 10.1186/ar2022
112. Lee HS Irigoyen P Kern M Lee A Batliwalla F Khalili H Wolfe F Lum RF Massarotti E Weisman M Bombardier C Karlson EW Criswell LA Vlietinck R Gregersen PK Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: A mixed picture in three large North American rheumatoid arthritis cohorts Arthritis Rheum 2007, 56:1745-1753. 10.1002/art.22703 17530703